Markets
Opinion
National
Politics
Companies
Economy
Business
World
Sport
Life
BusinessDay TV
E-Edition
Our Network
13 December 2020
5 Min Read
AstraZeneca to buy rare-disease specialist Alexion for $39bn
in
Companies
/
Healthcare
by
John Lauerman and James Paton
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe
Sign In
Related Articles
National
Solidarity Fund ‘not saying no’ to further Covid vaccine donation
World
Africa unlikely to get enough Covid-19 vaccine doses, Africa CDC head says
Companies
Renergen develops pioneering Covid-19 vaccine transport vessel
World
Vladimir Putin orders mass Covid-19 vaccinations from next week
World
Russia says data shows Sputnik 95% effective and prices vaccine at under $20
Loading ...
Loading ...
View Comments